Jenani, Fhaira B.
HRN: 22-19-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/19/2022
11/26/2022
IV
900mg
Iv
Tc Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes